VIDYA GOPALAKRISHNAN to Drug Resistance, Neoplasm
This is a "connection" page, showing publications VIDYA GOPALAKRISHNAN has written about Drug Resistance, Neoplasm.
Connection Strength
0.089
-
REST is a novel prognostic factor and therapeutic target for medulloblastoma. Mol Cancer Ther. 2012 Aug; 11(8):1713-1723.
Score: 0.040
-
The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res. 2010 Dec 15; 16(24):6060-70.
Score: 0.036
-
Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain. FEBS J. 2016 09; 283(18):3408-37.
Score: 0.013